Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctioncalcium ion binding

DCHS2 CELSR1 FAT2 BRAF ANKEF1 PCDHB6 DCHS1 ASTN2 PCDH8 CEMIP2

3.87e-057495610GO:0005509
GeneOntologyMolecularFunctionpoly(A) binding

HNRNPDL ZC3H14 LARP4

7.25e-0529563GO:0008143
GeneOntologyMolecularFunctionpoly-purine tract binding

HNRNPDL ZC3H14 LARP4

1.52e-0437563GO:0070717
GeneOntologyBiologicalProcesshomophilic cell adhesion via plasma membrane adhesion molecules

DCHS2 CELSR1 FAT2 PCDHB6 DCHS1 PCDH8

1.27e-05187576GO:0007156
GeneOntologyBiologicalProcessregulation of secretion of lysosomal enzymes

NR1H3 NR1H2

2.25e-053572GO:0090182
GeneOntologyBiologicalProcesscondensed mesenchymal cell proliferation

DCHS2 DCHS1

4.49e-054572GO:0072137
GeneOntologyBiologicalProcessestablishment of body hair planar orientation

CELSR1 ASTN2

4.49e-054572GO:0048105
GeneOntologyBiologicalProcessestablishment of body hair or bristle planar orientation

CELSR1 ASTN2

4.49e-054572GO:0048104
GeneOntologyBiologicalProcessmorphogenesis of a polarized epithelium

CELSR1 AJAP1 DCHS1 ASTN2

4.95e-0573574GO:0001738
GeneOntologyBiologicalProcessnegative regulation of pinocytosis

NR1H3 NR1H2

1.12e-046572GO:0048550
GeneOntologyBiologicalProcessnegative regulation of response to type II interferon

NR1H3 NR1H2

2.08e-048572GO:0060331
GeneOntologyBiologicalProcessnegative regulation of type II interferon-mediated signaling pathway

NR1H3 NR1H2

2.08e-048572GO:0060336
GeneOntologyBiologicalProcesspositive regulation of lipoprotein lipase activity

NR1H3 NR1H2

2.08e-048572GO:0051006
GeneOntologyBiologicalProcesscell-cell adhesion via plasma-membrane adhesion molecules

DCHS2 CELSR1 FAT2 PCDHB6 DCHS1 PCDH8

2.20e-04313576GO:0098742
GeneOntologyBiologicalProcessestablishment of planar polarity

CELSR1 DCHS1 ASTN2

2.45e-0444573GO:0001736
GeneOntologyBiologicalProcessestablishment of tissue polarity

CELSR1 DCHS1 ASTN2

2.61e-0445573GO:0007164
GeneOntologyBiologicalProcessregulation of pancreatic juice secretion

NR1H3 NR1H2

2.67e-049572GO:0090186
GeneOntologyBiologicalProcesspositive regulation of triglyceride lipase activity

NR1H3 NR1H2

2.67e-049572GO:0061365
GeneOntologyBiologicalProcesssecretion of lysosomal enzymes

NR1H3 NR1H2

3.33e-0410572GO:0033299
GeneOntologyBiologicalProcessnegative regulation of cholesterol storage

NR1H3 NR1H2

4.86e-0412572GO:0010887
GeneOntologyBiologicalProcesscell-cell adhesion

DCHS2 CELSR1 FAT2 MAP3K8 PAK4 PCDHB6 DCHS1 ASTN2 CBFB PCDH8

6.64e-0410775710GO:0098609
GeneOntologyBiologicalProcessphosphatidylcholine acyl-chain remodeling

NR1H3 NR1H2

6.68e-0414572GO:0036151
GeneOntologyBiologicalProcesspancreatic juice secretion

NR1H3 NR1H2

6.68e-0414572GO:0030157
GeneOntologyBiologicalProcessregulation of pinocytosis

NR1H3 NR1H2

6.68e-0414572GO:0048548
GeneOntologyBiologicalProcessregulation of response to type II interferon

NR1H3 NR1H2

7.70e-0415572GO:0060330
GeneOntologyBiologicalProcessregulation of type II interferon-mediated signaling pathway

NR1H3 NR1H2

7.70e-0415572GO:0060334
GeneOntologyBiologicalProcessnegative regulation of macrophage derived foam cell differentiation

NR1H3 NR1H2

7.70e-0415572GO:0010745
GeneOntologyBiologicalProcessprotein localization to chromatin

CHMP7 JARID2 RNF4

7.74e-0465573GO:0071168
GeneOntologyBiologicalProcessregulation of lipoprotein lipase activity

NR1H3 NR1H2

8.78e-0416572GO:0051004
GeneOntologyCellularComponentstereocilium base

TPRN PTPRQ

2.02e-048572GO:0120044
MousePhenodecreased inner hair cell stereocilia number

EPS8L2 TPRN PTPRQ

7.59e-0613433MP:0004534
MousePhenoabnormal cochlear hair cell stereociliary bundle morphology

EPS8L2 CELSR1 TPRN PTPRQ DCHS1

8.29e-0691435MP:0004521
MousePhenodecreased cochlear hair cell stereocilia number

EPS8L2 TPRN PTPRQ

6.71e-0526433MP:0004523
DomainCadherin_CS

DCHS2 CELSR1 FAT2 PCDHB6 DCHS1 PCDH8

7.90e-07109556IPR020894
DomainCADHERIN_1

DCHS2 CELSR1 FAT2 PCDHB6 DCHS1 PCDH8

9.77e-07113556PS00232
DomainCadherin

DCHS2 CELSR1 FAT2 PCDHB6 DCHS1 PCDH8

9.77e-07113556PF00028
DomainCADHERIN_2

DCHS2 CELSR1 FAT2 PCDHB6 DCHS1 PCDH8

1.03e-06114556PS50268
Domain-

DCHS2 CELSR1 FAT2 PCDHB6 DCHS1 PCDH8

1.03e-061145562.60.40.60
DomainCA

DCHS2 CELSR1 FAT2 PCDHB6 DCHS1 PCDH8

1.08e-06115556SM00112
DomainCadherin-like

DCHS2 CELSR1 FAT2 PCDHB6 DCHS1 PCDH8

1.14e-06116556IPR015919
DomainCadherin

DCHS2 CELSR1 FAT2 PCDHB6 DCHS1 PCDH8

1.26e-06118556IPR002126
DomainLiver_X_rcpt

NR1H3 NR1H2

8.51e-062552IPR023257
DomainPTB

EPS8L2 TNS2

2.36e-048552PF08416
DomainPTB

EPS8L2 TNS2

2.36e-048552IPR013625
DomainRRM

HNRNPDL RBM12B LARP4 SPEN

3.80e-03217554SM00360
DomainRRM_dom

HNRNPDL RBM12B LARP4 SPEN

4.46e-03227554IPR000504
DomainZnf_FYVE-rel

ZFYVE26 RIMS2

4.50e-0334552IPR017455
DomainRRM

HNRNPDL RBM12B LARP4 SPEN

4.68e-03230554PS50102
DomainZnf_FYVE

ZFYVE26 RIMS2

5.59e-0338552IPR000306
DomainLAM_G_DOMAIN

CELSR1 FAT2

5.59e-0338552PS50025
Domain-

HNRNPDL RBM12B LARP4 SPEN

5.75e-032445543.30.70.330
DomainPTB

EPS8L2 TNS2

6.18e-0340552SM00462
DomainZF_FYVE

ZFYVE26 RIMS2

6.18e-0340552PS50178
DomainLaminin_G_2

CELSR1 FAT2

6.18e-0340552PF02210
DomainPTB/PI_dom

EPS8L2 TNS2

6.49e-0341552IPR006020
DomainNucleotide-bd_a/b_plait

HNRNPDL RBM12B LARP4 SPEN

6.99e-03258554IPR012677
DomainLamG

CELSR1 FAT2

7.44e-0344552SM00282
Domainzf-C4

NR1H3 NR1H2

8.11e-0346552PF00105
DomainZnf_hrmn_rcpt

NR1H3 NR1H2

8.11e-0346552IPR001628
DomainNuclear_hrmn_rcpt

NR1H3 NR1H2

8.11e-0346552IPR001723
DomainNUCLEAR_REC_DBD_2

NR1H3 NR1H2

8.11e-0346552PS51030
DomainNUCLEAR_REC_DBD_1

NR1H3 NR1H2

8.11e-0346552PS00031
DomainZnF_C4

NR1H3 NR1H2

8.11e-0346552SM00399
Domain-

NR1H3 NR1H2

8.46e-03475521.10.565.10
DomainHOLI

NR1H3 NR1H2

8.81e-0348552SM00430
DomainNucl_hrmn_rcpt_lig-bd

NR1H3 NR1H2

8.81e-0348552IPR000536
DomainHormone_recep

NR1H3 NR1H2

8.81e-0348552PF00104
Domain-

NR1H3 NR1H2

1.23e-02575523.30.50.10
DomainLaminin_G

CELSR1 FAT2

1.27e-0258552IPR001791
PathwayREACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_LIMIT_CHOLESTEROL_UPTAKE

NR1H3 NR1H2

4.36e-055302M29791
PathwayREACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_TRIGLYCERIDE_LIPOLYSIS_IN_ADIPOSE

NR1H3 NR1H2

4.36e-055302M29792
PathwayREACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS

NR1H3 NR1H2

6.53e-056302MM15663
PathwayREACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS

NR1H3 NR1H2

1.56e-049302M29809
PathwayREACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_LIPOGENESIS

NR1H3 NR1H2

1.56e-049302M29789
PathwayREACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING

NR1H3 NR1H2

3.37e-0413302MM15622
PathwayPID_TCR_RAS_PATHWAY

BRAF MAP3K8

3.92e-0414302M134
PathwayKEGG_RENAL_CELL_CARCINOMA

EGLN3 BRAF PAK4

4.32e-0470303M13266
PathwayREACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION

NR1H3 NR1H2

5.16e-0416302M27761
PathwayREACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION

NR1H3 NR1H2

5.16e-0416302MM15506
Pubmed

Expression of mouse dchs1, fjx1, and fat-j suggests conservation of the planar cell polarity pathway identified in Drosophila.

DCHS2 FAT2 DCHS1

1.53e-07758316059920
Pubmed

Liver X receptor beta deficiency attenuates autoimmune-associated neuroinflammation in a T cell-dependent manner.

NR1H3 NR1H2

2.73e-06258234481107
Pubmed

LXR deficiency confers increased protection against visceral Leishmania infection in mice.

NR1H3 NR1H2

2.73e-06258221103366
Pubmed

Nuclear receptor liver X receptor is O-GlcNAc-modified in response to glucose.

NR1H3 NR1H2

2.73e-06258219933273
Pubmed

Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries.

NR1H3 NR1H2

2.73e-06258215539633
Pubmed

Liver X receptors regulate cerebrospinal fluid production.

NR1H3 NR1H2

2.73e-06258226324101
Pubmed

Suppression of beta-catenin signaling by liver X receptor ligands.

NR1H3 NR1H2

2.73e-06258218983830
Pubmed

Identification of biological markers of liver X receptor (LXR) activation at the cell surface of human monocytes.

NR1H3 NR1H2

2.73e-06258223185273
Pubmed

The liver X receptor-{beta} is essential for maintaining cholesterol homeostasis in the testis.

NR1H3 NR1H2

2.73e-06258215761042
Pubmed

LXR activation inhibits chemokine-induced CD4-positive lymphocyte migration.

NR1H3 NR1H2

2.73e-06258220364260
Pubmed

Liver X receptor-α/β expression ratio is increased in ACTH-secreting pituitary adenomas.

NR1H3 NR1H2

2.73e-06258221356276
Pubmed

Levels of liver X receptors in testicular biopsies of patients with azoospermia.

NR1H3 NR1H2

2.73e-06258224842676
Pubmed

LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes.

NR1H3 NR1H2

2.73e-06258211149950
Pubmed

Liver X receptor gene polymorphisms and adipose tissue expression levels in obesity.

NR1H3 NR1H2

2.73e-06258217108812
Pubmed

Liver X receptors regulate natural killer T cell population and antitumor activity in the liver of mice.

NR1H3 NR1H2

2.73e-06258234799646
Pubmed

Functional and genetic analysis in type 2 diabetes of liver X receptor alleles--a cohort study.

NR1H3 NR1H2

2.73e-06258219292929
Pubmed

Oxysterol stimulation of epidermal differentiation is mediated by liver X receptor-beta in murine epidermis.

NR1H3 NR1H2

2.73e-06258211851872
Pubmed

Liver X receptor signaling is a determinant of stellate cell activation and susceptibility to fibrotic liver disease.

NR1H3 NR1H2

2.73e-06258221134374
Pubmed

Different roles of liver X receptor alpha and beta in lipid metabolism: effects of an alpha-selective and a dual agonist in mice deficient in each subtype.

NR1H3 NR1H2

2.73e-06258216325781
Pubmed

Macrophages release plasma membrane-derived particles rich in accessible cholesterol.

NR1H3 NR1H2

2.73e-06258230127022
Pubmed

Liver X receptor β controls thyroid hormone feedback in the brain and regulates browning of subcutaneous white adipose tissue.

NR1H3 NR1H2

2.73e-06258226504234
Pubmed

Lack of association between LXRα and LXRβ gene polymorphisms and prevalence of metabolic syndrome: a case-control study of an Iranian population.

NR1H3 NR1H2

2.73e-06258224100084
Pubmed

Liver X receptors as integrators of metabolic and inflammatory signaling.

NR1H3 NR1H2

2.73e-06258216511593
Pubmed

Liver X receptors regulate adrenal cholesterol balance.

NR1H3 NR1H2

2.73e-06258216823488
Pubmed

Myelin-derived lipids modulate macrophage activity by liver X receptor activation.

NR1H3 NR1H2

2.73e-06258222984598
Pubmed

Activation of liver X receptors inhibits cadmium-induced apoptosis of human renal proximal tubular cells.

NR1H3 NR1H2

2.73e-06258225980575
Pubmed

Liver X receptor in cholesterol metabolism.

NR1H3 NR1H2

2.73e-06258219837721
Pubmed

Short-term adaptation of postprandial lipoprotein secretion and intestinal gene expression to a high-fat diet.

NR1H3 NR1H2

2.73e-06258219196952
Pubmed

Liver X receptors regulate de novo lipogenesis in a tissue-specific manner in C57BL/6 female mice.

NR1H3 NR1H2

2.73e-06258221521718
Pubmed

Molecular basis for repression of liver X receptor-mediated gene transcription by receptor-interacting protein 140.

NR1H3 NR1H2

2.73e-06258217391100
Pubmed

BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis.

NR1H3 NR1H2

2.73e-06258211792716
Pubmed

Accumulation of foam cells in liver X receptor-deficient mice.

NR1H3 NR1H2

2.73e-06258212196343
Pubmed

Separating the Anti-Inflammatory and Diabetogenic Effects of Glucocorticoids Through LXRβ Antagonism.

NR1H3 NR1H2

2.73e-06258228324010
Pubmed

Liver X receptors inhibit human monocyte-derived macrophage foam cell formation by inhibiting fluid-phase pinocytosis of LDL.

NR1H3 NR1H2

2.73e-06258217693624
Pubmed

Dyslipidemia alters sperm maturation and capacitation in LXR-null mice.

NR1H3 NR1H2

2.73e-06258228971895
Pubmed

Liver X receptors alpha and beta promote myelination and remyelination in the cerebellum.

NR1H3 NR1H2

2.73e-06258226023184
Pubmed

Activation of the liver X receptor prevents lipopolysaccharide-induced lung injury.

NR1H3 NR1H2

2.73e-06258219717840
Pubmed

Absence of nuclear receptors LXRs impairs immune response to androgen deprivation and leads to prostate neoplasia.

NR1H3 NR1H2

2.73e-06258233284790
Pubmed

Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo.

NR1H3 NR1H2

2.73e-06258220110577
Pubmed

Lxrα regulates the androgen response in prostate epithelium.

NR1H3 NR1H2

2.73e-06258222547570
Pubmed

COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.

BRAF MAP3K8

2.73e-06258221107320
Pubmed

Liver X receptor is a key regulator of cytokine release in human monocytes.

NR1H3 NR1H2

2.73e-06258217724434
Pubmed

Liver X receptor mediates hepatitis B virus X protein-induced lipogenesis in hepatitis B virus-associated hepatocellular carcinoma.

NR1H3 NR1H2

2.73e-06258219105208
Pubmed

Novel role for the liver X nuclear receptor in the suppression of lung inflammatory responses.

NR1H3 NR1H2

2.73e-06258217766241
Pubmed

Liver X receptors contribute to periodontal pathogen-elicited inflammation and oral bone loss.

NR1H3 NR1H2

2.73e-06258225946408
Pubmed

Liver X Receptor exerts a protective effect against the oxidative stress in the peripheral nerve.

NR1H3 NR1H2

2.73e-06258229410501
Pubmed

Liver X receptors regulate hepatic F4/80 + CD11b+ Kupffer cells/macrophages and innate immune responses in mice.

NR1H3 NR1H2

2.73e-06258229915246
Pubmed

The medicinal chemistry of liver X receptor (LXR) modulators.

NR1H3 NR1H2

2.73e-06258224832115
Pubmed

Liver X receptor modulates diabetic retinopathy outcome in a mouse model of streptozotocin-induced diabetes.

NR1H3 NR1H2

2.73e-06258222891211
Pubmed

Improved metabolic control by depletion of Liver X Receptors in mice.

NR1H3 NR1H2

2.73e-06258216876124
Pubmed

Liver X receptors bridge hepatic lipid metabolism and inflammation.

NR1H3 NR1H2

2.73e-06258222257474
Pubmed

Liver X receptor activation stimulates insulin secretion via modulation of glucose and lipid metabolism in pancreatic beta-cells.

NR1H3 NR1H2

2.73e-06258215561926
Pubmed

Liver X receptors preserve renal glomerular integrity under normoglycaemia and in diabetes in mice.

NR1H3 NR1H2

2.73e-06258224201575
Pubmed

Liver X receptors control IgE expression in B cells.

NR1H3 NR1H2

2.73e-06258219380774
Pubmed

Liver X receptors interfere with the deleterious effect of diethylstilbestrol on testicular physiology.

NR1H3 NR1H2

2.73e-06258224333430
Pubmed

Liver X receptor stimulates cholesterol efflux and inhibits expression of proinflammatory mediators in human airway smooth muscle cells.

NR1H3 NR1H2

2.73e-06258217405904
Pubmed

Lack of liver X receptors leads to cell proliferation in a model of mouse dorsal prostate epithelial cell.

NR1H3 NR1H2

2.73e-06258223554947
Pubmed

Characterization of liver X receptor expression and function in human skin and the pilosebaceous unit.

NR1H3 NR1H2

2.73e-06258217845217
Pubmed

Ablation of Liver X receptors α and β leads to spontaneous peripheral squamous cell lung cancer in mice.

NR1H3 NR1H2

2.73e-06258227335465
Pubmed

Liver X receptors are negative regulators of cardiac hypertrophy via suppressing NF-kappaB signalling.

NR1H3 NR1H2

2.73e-06258219487338
Pubmed

A novel principle for partial agonism of liver X receptor ligands. Competitive recruitment of activators and repressors.

NR1H3 NR1H2

2.73e-06258216354658
Pubmed

LXRβ is required for glucocorticoid-induced hyperglycemia and hepatosteatosis in mice.

NR1H3 NR1H2

2.73e-06258221123945
Pubmed

Oxysterol nuclear receptor LXRbeta regulates cholesterol homeostasis and contractile function in mouse uterus.

NR1H3 NR1H2

2.73e-06258217166844
Pubmed

Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice.

NR1H3 NR1H2

2.73e-06258211238557
Pubmed

Phosphorylation of the liver X receptors.

NR1H3 NR1H2

2.73e-06258216904112
Pubmed

Structural characterisation of the mouse nuclear oxysterol receptor genes LXRalpha and LXRbeta.

NR1H3 NR1H2

2.73e-06258210675617
Pubmed

Reciprocal regulation of hepatic and adipose lipogenesis by liver X receptors in obesity and insulin resistance.

NR1H3 NR1H2

2.73e-06258223823481
Pubmed

Activation of liver X receptors suppresses inflammatory gene expressions and transcriptional corepressor clearance in rheumatoid arthritis fibroblast like synoviocytes.

NR1H3 NR1H2

2.73e-06258222990668
Pubmed

Liver X Receptors (LXRs) Alpha and Beta Play Distinct Roles in the Mouse Epididymis.

NR1H3 NR1H2

2.73e-06258226792941
Pubmed

Genetic variation within the NR1H2 gene encoding liver X receptor β associates with insulin secretion in subjects at increased risk for type 2 diabetes.

NR1H3 NR1H2

2.73e-06258221042792
Pubmed

Phospholipase A(2)-modified low-density lipoprotein activates liver X receptor in human macrophages.

NR1H3 NR1H2

2.73e-06258222367754
Pubmed

Liver X receptor (LXR) regulation of the LXRalpha gene in human macrophages.

NR1H3 NR1H2

2.73e-06258211546778
Pubmed

Identification of the Functions of Liver X Receptor-β in Sertoli Cells Using a Targeted Expression-Rescue Model.

NR1H3 NR1H2

2.73e-06258226402841
Pubmed

Stromal growth and epithelial cell proliferation in ventral prostates of liver X receptor knockout mice.

NR1H3 NR1H2

2.73e-06258219122149
Pubmed

Both liver-X receptor (LXR) isoforms control energy expenditure by regulating brown adipose tissue activity.

NR1H3 NR1H2

2.73e-06258221173252
Pubmed

LXR agonists promote the proliferation of neural progenitor cells through MEK-ERK pathway.

NR1H3 NR1H2

2.73e-06258228034754
Pubmed

Adipocytic differentiation and liver x receptor pathways regulate the accumulation of triacylglycerols in human vascular smooth muscle cells.

NR1H3 NR1H2

2.73e-06258215548517
Pubmed

Gene expression profiling in adipose tissue indicates different transcriptional mechanisms of liver X receptors alpha and beta, respectively.

NR1H3 NR1H2

2.73e-06258214521951
Pubmed

Reduced fertility and inability of oocytes to resume meiosis in mice deficient of the Lxr genes.

NR1H3 NR1H2

2.73e-06258216895745
Pubmed

LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms.

NR1H3 NR1H2

2.73e-06258219426978
Pubmed

Liver X receptors regulate adrenal steroidogenesis and hypothalamic-pituitary-adrenal feedback.

NR1H3 NR1H2

2.73e-06258216973760
Pubmed

Skeletal muscle as a target of LXR agonist after long-term treatment: focus on lipid homeostasis.

NR1H3 NR1H2

2.73e-06258224368671
Pubmed

Separate and overlapping metabolic functions of LXRalpha and LXRbeta in C57Bl/6 female mice.

NR1H3 NR1H2

2.73e-06258219690071
Pubmed

Multiple roles of the nuclear receptors for oxysterols liver X receptor to maintain male fertility.

NR1H3 NR1H2

2.73e-06258217341595
Pubmed

Pharmacological activation of LXR in utero directly influences ABC transporter expression and function in mice but does not affect adult cholesterol metabolism.

NR1H3 NR1H2

2.73e-06258218840761
Pubmed

Regulation of hepatic fatty acid elongase 5 by LXRalpha-SREBP-1c.

NR1H3 NR1H2

2.73e-06258219136075
Pubmed

Liver X receptors as insulin-mediating factors in fatty acid and cholesterol biosynthesis.

NR1H3 NR1H2

2.73e-06258211781314
Pubmed

Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer.

NR1H3 NR1H2

2.73e-06258234085098
Pubmed

Activation of LXRs prevents bile acid toxicity and cholestasis in female mice.

NR1H3 NR1H2

2.73e-06258217256725
Pubmed

Expression of the liver X receptor alpha and beta in embryonic and adult mice.

NR1H3 NR1H2

2.73e-06258215052659
Pubmed

Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors.

NR1H3 NR1H2

2.73e-06258217563384
Pubmed

Androgen deprivation by activating the liver X receptor.

NR1H3 NR1H2

2.73e-06258218450964
Pubmed

LXRbeta is required for adipocyte growth, glucose homeostasis, and beta cell function.

NR1H3 NR1H2

2.73e-06258215831500
Pubmed

Interplay between LXR and Wnt/β-catenin signaling in the negative regulation of peripheral myelin genes by oxysterols.

NR1H3 NR1H2

2.73e-06258221715627
Pubmed

Liver X receptors contribute to the protective immune response against Mycobacterium tuberculosis in mice.

NR1H3 NR1H2

2.73e-06258219436111
Pubmed

Brain endogenous liver X receptor ligands selectively promote midbrain neurogenesis.

NR1H3 NR1H2

2.73e-06258223292650
Pubmed

Differential regulation of gene expression by LXRs in response to macrophage cholesterol loading.

NR1H3 NR1H2

2.73e-06258223686114
Pubmed

Dietary cholesterol-induced post-testicular infertility.

NR1H3 NR1H2

2.73e-06258222073227
Pubmed

Activation of Liver X Receptor Attenuates Oleic Acid-Induced Acute Respiratory Distress Syndrome.

NR1H3 NR1H2

2.73e-06258227520356
Pubmed

Nuclear oxysterol receptors, LXRs, are involved in the maintenance of mouse caput epididymidis structure and functions.

NR1H3 NR1H2

2.73e-06258215525595
Cytoband10p11.23

JCAD MAP3K8

2.37e-041858210p11.23
Cytoband4q31.3

DCHS2 FHDC1

7.12e-04315824q31.3
GeneFamilyCadherin related

DCHS2 FAT2 DCHS1

5.71e-061738324
GeneFamilyMitogen-activated protein kinase kinase kinases|RAF family

BRAF MAP3K8

1.15e-0324382654
GeneFamilyNuclear hormone receptors

NR1H3 NR1H2

4.75e-034938271
GeneFamilyRNA binding motif containing

HNRNPDL RBM12B SPEN

1.00e-02213383725
GeneFamilyActins|Deafness associated genes

TPRN PTPRQ

2.35e-021133821152
ToppCell3'-Distal_airway-Endothelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

JCAD PAK4 TNS2 CEMIP2 STC1

5.81e-061975859ffb823c0f3f23cc85f9fd3ca24f77817e90bd86
ToppCell3'-Distal_airway-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

JCAD PAK4 TNS2 CEMIP2 STC1

5.81e-06197585ca6bce1a92c6326f41a6300c31da02386bafa152
ToppCell3'-Distal_airway-Endothelial-Blood_vessel_EC|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

JCAD PAK4 TNS2 CEMIP2 STC1

5.95e-061985853aae7d146ebbb34da3239041a7c0334abff2597f
ToppCell10x3'2.3-week_14-16-Endothelial|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

JCAD DCHS1 KCNN3 CEMIP2 STC1

6.10e-0619958541f046646fff65b7e51b63d3204f76ef32054781
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

JARID2 DMXL2 MAP3K8 NR1H3 MMP19

6.10e-06199585667b8b47a5b388506e3177b46747267fad8024f6
ToppCellSepsis-URO-Lymphocyte-B-Plasmablast|URO / Disease, condition lineage and cell class

ZC3H14 EGLN3 EPS8L2 KCNN3 CHPF

6.10e-061995850df6cafb7f3b607cbe80b6f25b4fd62d421d01ee
ToppCell10x3'2.3-week_14-16-Endothelial-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

JCAD DCHS1 KCNN3 CEMIP2 STC1

6.10e-06199585ef7f7f7c861827574b120f48cf4052c563929081
ToppCell10x5'v1-week_14-16-Endothelial-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

JCAD EGLN3 DCHS1 CEMIP2 STC1

6.25e-062005852488aa12970a43a5af352e2c36c73884d73a1cc5
ToppCell10x5'v1-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

JCAD DCHS1 KCNN3 CEMIP2 STC1

6.25e-0620058577ac1aa73c16a4f595ff01c6b4e171e0b8fed1e6
ToppCell10x5'v1-week_14-16-Endothelial|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

JCAD EGLN3 DCHS1 CEMIP2 STC1

6.25e-06200585e786544cf6f891550c4be55ebb4928c92297b504
ToppCellTCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9

JARID2 RBM12B SSTR5 SPEN

4.26e-05149584768877bade04ca0321593b8470b5011ad8270431
ToppCellLPS-IL1RA+antiTNF-Unknown-Endothelial-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

JCAD DCHS2 DCHS1 STC1

4.85e-0515458416fdafb5c64d2db321554f87129a962d113f1668
ToppCellBAL-Mild-cDC_5|Mild / Compartment, Disease Groups and Clusters

EGLN3 EPS8L2 ZBTB21 MMP19

5.77e-051615847a6e8ed0b5d999efce8945d8083ab01d71be9a92
ToppCell368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|368C / Donor, Lineage, Cell class and subclass (all cells)

JCAD DCHS2 EGLN3 PAK4

6.49e-0516658430a991fc3275b571d53bd0976df4789e5d40b01d
ToppCell368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|368C / Donor, Lineage, Cell class and subclass (all cells)

JCAD DCHS2 EGLN3 PAK4

6.49e-0516658476b4cd32698900797ec009f17e50ea7ae36b85f4
ToppCellnormal-na-Lymphocytic_B-B_plasma-male|normal / PBMC cell types (v2) per disease, treatment status, and sex

CELSR1 ANKEF1 KCNN3 CHPF

7.12e-05170584c5b87974dfddf9780051f7f5693eeeb0c606a3fe
ToppCelldroplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EGLN3 CELSR1 FHDC1 STC1

7.96e-05175584f6e1d7297a4dbb38e1ab4f738d91f0e62abaee69
ToppCellControl-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

EPS8L2 CELSR1 AJAP1 PTPRQ

8.32e-051775849af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCellfacs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

EGLN3 EPS8L2 FHDC1 STC1

8.88e-0518058467c5068b660cd5e727a665cefe3bd5f8ae887221
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

DCHS2 MAP3K8 CEMIP2 STC1

8.88e-05180584b514c55e52b46e8a1a2f09ed2c59a7683367a505
ToppCelldroplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

EPS8L2 FHDC1 CEMIP2 STC1

9.07e-05181584136b0c60680068838d184d32aa99d7bea8718dbc
ToppCell10x3'2.3-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

JCAD DCHS1 KCNN3 STC1

9.27e-05182584997d37ca2af661c92a56add888762724dfccc890
ToppCellSubstantia_nigra-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Shox2_(peripeduncular_nucleus_&_posterior_intralaminar_thalamic_nucleus_(PP_&_PIL))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

CHRDL1 RSPH6A SSTR5

1.00e-046958372031d97bf3a3f3e8fe2ad1130c766e39b3b4c46
ToppCellSubstantia_nigra-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Shox2_(peripeduncular_nucleus_&_posterior_intralaminar_thalamic_nucleus_(PP_&_PIL))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

CHRDL1 RSPH6A SSTR5

1.00e-046958320bda1222efe784b025c6b311a7813b3b562ec71
ToppCellNS-critical-LOC-Epithelial-Basal|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

EGLN3 FAT2 PYCARD-AS1 STC1

1.01e-04186584c28f62524637c7eb9c43c9ec38fb12dfec6f5566
ToppCelldroplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

EPS8L2 TNS2 CEMIP2 STC1

1.01e-041865849c7924875f70420720149287c500b4dfa8d24673
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

JCAD ISM1 FOXL1 STC1

1.03e-04187584387cb27c8a20031cd87381a9e1172f1f62e1488b
ToppCelldroplet-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

EPS8L2 TNS2 CEMIP2 STC1

1.03e-0418758412129e02638c20d9b7c1c6e512d48bfd966e1029
ToppCelldroplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

EPS8L2 TNS2 CEMIP2 STC1

1.03e-0418758483930ef55191eff9006113feaeabb3c2fa21fd05
ToppCell(0)_Myeloid-(011)_pDC|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization)

EGLN3 EPS8L2 AJAP1 CHPF

1.05e-04188584a81b5d840490d6a636fe168f8cff2c4984369f09
ToppCelltumor_Lymph_Node_/_Brain-Fibroblasts-Undetermined|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass

ISM1 CHRDL1 TNS2 FOXL1

1.05e-041885848231e635706a296db6b6da1029a33bbc1b52478e
ToppCellfacs-MAT-Fat-3m|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

JCAD KCNN3 CHRDL1 CHPF

1.05e-041885847da9750255efbc5cf9aed7e3105a337fac63b9f0
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

JCAD ISM1 FOXL1 STC1

1.07e-041895840abc7a4900cc9033bc1be69b770ccc54a6bf41b4
ToppCellwk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

JCAD ISM1 FOXL1 STC1

1.09e-0419058471a00f63fdd4eb4cc6f190d37e7a0417cdaafacb
ToppCellControl-pDC|Control / Disease condition and Cell class

EGLN3 EPS8L2 AJAP1 CHPF

1.12e-04191584543e1437a52d04436862dd1c27b4fae95c44fcc8
ToppCell10x5'v1-week_12-13-Endothelial-stroma-tip_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

JCAD DCHS1 TNS2 STC1

1.12e-04191584cf1a67b7c0d5c0dc5d4d59faf9d9b1a3a1fb00e0
ToppCellControl-pDC-|Control / Disease condition and Cell class

EGLN3 EPS8L2 AJAP1 CHPF

1.12e-041915841d7b0fae4d114d6db933c18b4eb2066ffa61356d
ToppCellLAM-Endothelial-LymEndo|LAM / Condition, Lineage and Cell class

JCAD EGLN3 CHRDL1 STC1

1.16e-0419358468eadc91c2d89edd2412e86dfe134dd7c0ef6ee9
ToppCellRA-08._Macrophage|World / Chamber and Cluster_Paper

JARID2 DMXL2 MAP3K8 CEMIP2

1.16e-041935845fd22db1825d105709fcc0aa4955c99a117e3c82
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

JARID2 DMXL2 MAP3K8 MMP19

1.16e-041935845703a6faaee82cbad5ce73429bdf1b0f47b37ee0
ToppCellCOVID-19_Mild|World / Disease condition and Cell class

ZBP1 BRAF MAP3K8 CEMIP2

1.16e-041935847256a5a491536c525b31ae96d47ab5c6303cb73a
ToppCell10x5'v1-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

JCAD DCHS1 KCNN3 STC1

1.19e-041945848a4be91414a2e69dd410aa75791f16008204c9a1
ToppCellControl-Myeloid-Macrophage|World / Disease state, Lineage and Cell class

JARID2 DMXL2 MAP3K8 MMP19

1.19e-04194584c35bf04d5e7450cb6679a036fcabb1b28f409f29
ToppCellRA-08._Macrophage|RA / Chamber and Cluster_Paper

JARID2 DMXL2 MAP3K8 CEMIP2

1.19e-04194584ac26e5c71d5069622de72fa25a9c920887ac2c19
ToppCellASK440-Endothelial-Endothelium|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq

JCAD DCHS1 TNS2 STC1

1.21e-04195584304f0dc91bb57e98b0ca31d6bfb3ff9364e4da56
ToppCell3'-Distal_airway-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

JCAD PAK4 TNS2 STC1

1.21e-0419558483da75d210ae9c2a94018d70cb9e833b37004c4e
ToppCellASK440-Endothelial|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq

JCAD KCNN3 CHRDL1 STC1

1.21e-041955841cdaab17866a1e5170e0f6bfcc69134425fdd8df
ToppCellControl-Myeloid|Control / Disease state, Lineage and Cell class

JARID2 DMXL2 MAP3K8 MMP19

1.21e-0419558446ce2e403ca5d757e5ba17349b6c7ce5cde1f195
ToppCell11.5-Distal-Mesenchymal-Airway_Smooth_Muscle|Distal / Age, Tissue, Lineage and Cell class

ISM1 CHRDL1 CHPF STC1

1.23e-0419658405530fe7a5681c2f39b95016cd22ef99d6ac0430
ToppCellControl-Myeloid-Macrophage|Control / Disease state, Lineage and Cell class

JARID2 DMXL2 MAP3K8 MMP19

1.23e-04196584e2c2a30fa3ee3034fbde5335be169e880dde622d
ToppCelldistal-1-Hematologic-Plasma|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

ZBP1 KCNN3 RIMS2 CHPF

1.26e-04197584f5499bfa9dbc111f12563b7006bc45c2423ad0cd
ToppCell3'-Distal_airway-Endothelial-Blood_vessel_EC-capillary_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

JCAD PAK4 CEMIP2 STC1

1.26e-041975846ac8d3e3f573e3848ab33e4df66dfaf8f948ea6c
ToppCellCOVID-19_Mild|World / Disease group, lineage and cell class

ZBP1 BRAF MAP3K8 CEMIP2

1.26e-041975845c33454b10023decd2f5ccda9229b6512659711e
ToppCell3'-Distal_airway-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

JCAD PAK4 CEMIP2 STC1

1.26e-04197584e3be7758a92f12e0a423394822957e1b7f995110
ToppCellSepsis-URO-Others|URO / Disease, condition lineage and cell class

EPS8L2 PAK4 DCHS1 CHPF

1.28e-041985846caab5266da666cfbe92ac1ace26ad2004e5aa09
ToppCellSepsis-URO-Others-RBC|URO / Disease, condition lineage and cell class

EPS8L2 PAK4 DCHS1 CHPF

1.28e-04198584d35e9d0952b3f7cd5d0d1a69bad2ae81af8eed50
ToppCellPBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)

ZBP1 BRAF MAP3K8 CEMIP2

1.28e-0419858444417089b62056269cac38d3134ff209c05b7007
ToppCell10x5'v1-week_12-13-Endothelial-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

JCAD DCHS1 TNS2 STC1

1.28e-04198584122215d9288533ad03562cf777e846504863df9a
ToppCell10x5'v1-week_12-13-Endothelial|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

JCAD DCHS1 TNS2 STC1

1.28e-04198584307dd09e6bc820a148f3000f18dae7aedba4be0b
ToppCellPBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ZBP1 BRAF MAP3K8 CEMIP2

1.28e-0419858428ef3fc4c17dcb765537b75917f7db78baa522db
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

JCAD DCHS1 KCNN3 TNS2

1.31e-04199584f35e9c05d0a0339ff691b38564da7aad8e9218aa
ToppCell10x3'2.3-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

JCAD KCNN3 CEMIP2 STC1

1.31e-041995841c69395c9305b6ecb0a826d46c8e8ec95795ad6d
ToppCell3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

JCAD PAK4 CEMIP2 STC1

1.31e-041995848db1acdcabf97f01b9ca17456c48ec8ac4928390
ToppCell11.5-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class

ISM1 CHRDL1 CHPF STC1

1.31e-041995841a8c77d241bd817a195e1532fd25f51358cb1ff1
ToppCellSepsis-URO-Lymphocyte-T/NK-CD8+_Tcm|URO / Disease, condition lineage and cell class

CEP68 EPS8L2 ISM1 RIMS2

1.31e-04199584eb085f9f2c837494548c26bb61e8b74516539e23
ToppCellmedial-Endothelial-Capillary|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

JCAD PAK4 CEMIP2 STC1

1.33e-04200584fd4dcdc67db2a5dbdd54bd2ae975c66df904d4d8
ToppCellmedial-2-Endothelial-Capillary|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

JCAD PAK4 CEMIP2 STC1

1.33e-04200584e4f390dfd4dd25600f0f7a17c5523283a5966e92
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW10-Macroglial-Astrocyte|GW10 / Sample Type, Dataset, Time_group, and Cell type.

EGLN3 MAP3K8 FAM181A CEMIP2

1.33e-0420058498a994692440cb4f505b050276f0c8022c814a21
ToppCellmedial-Endothelial-Capillary-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

JCAD PAK4 CEMIP2 STC1

1.33e-042005844291b5453e98e20ec8150a96ccc865a5964bc645
ToppCell10x5'v1-week_14-16-Endothelial-stroma-sinusoidal_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

EGLN3 DCHS1 CEMIP2 STC1

1.33e-04200584ae429f2de652cc1976e63644781197e9ce0e70c8
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW10-Macroglial|GW10 / Sample Type, Dataset, Time_group, and Cell type.

EGLN3 MAP3K8 FAM181A CEMIP2

1.33e-04200584ef222dc4a205d670172dae74990bdb952ac92e5b
ToppCellEntopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Tcf7l2_(Entopeduncular_Nucleus_(Ent))--|Entopeduncular / BrainAtlas - Mouse McCarroll V32

DCHS2 MROH7 RSPH6A

2.21e-049058327865bd63dda0624e62a3b713464a490b588d3ae
ToppCellEntopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Tcf7l2_(Entopeduncular_Nucleus_(Ent))|Entopeduncular / BrainAtlas - Mouse McCarroll V32

DCHS2 MROH7 RSPH6A

2.21e-04905838c2eb7444f938faade7c81a60c004252d588c80b
ToppCellEntopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Tcf7l2_(Entopeduncular_Nucleus_(Ent))-|Entopeduncular / BrainAtlas - Mouse McCarroll V32

DCHS2 MROH7 RSPH6A

2.21e-04905834bc53b521abb79fc53ac912f1dc2e3c55426b2e0
ComputationalNeighborhood of CBFB

HNRNPDL RNF4 CBFB

1.55e-0430383GNF2_CBFB
Diseaseclear cell renal cell carcinoma (is_marker_for)

EGLN3 MAP3K8 PAK4

3.58e-0533573DOID:4467 (is_marker_for)
DiseaseDEAFNESS, AUTOSOMAL RECESSIVE (disorder)

DMXL2 PTPRQ

2.82e-0413572C1846647
DiseaseLung cancer

BRAF MAP3K8

3.29e-0414572cv:C0242379
DiseaseLUNG CANCER

BRAF MAP3K8

3.29e-0414572211980
DiseaseNeoplasm of lung

BRAF MAP3K8

3.29e-0414572cv:C0024121
DiseaseOsteoarthritis of hip

ASTN2 CHADL

6.81e-0420572C0029410
DiseaseMalignant neoplasm of breast

BRAF ANKEF1 MROH7 ASTN2 ZFYVE26 CBFB SPEN PCDH8

1.02e-031074578C0006142
Diseaseintelligence, response to cranial radiation therapy

DCHS2 FHDC1

1.34e-0328572EFO_0004337, EFO_0010950
DiseaseLymphoma, Non-Hodgkin

BRAF SPEN

1.75e-0332572C0024305

Protein segments in the cluster

PeptideGeneStartEntry
FRPADEDHRNQFGQR

BRAF

346

P15056
SRAHQPQASDANREP

CEP68

76

Q76N32
PRARRAHRPRDQAAA

AJAP1

96

Q9UKB5
NVTDSSRFNRDHPPE

ANKEF1

461

Q9NU02
PLRNAATRTFHDPNA

DMXL2

706

Q8TDJ6
RRRHPDDAGQFAVAL

CELSR1

2326

Q9NYQ6
DRRNPHEVQPSYATR

EGLN3

191

Q9H6Z9
PPRRANHVSREDEFG

ASTN2

301

O75129
RNSNPSRHELNPFIR

MROH7

166

Q68CQ1
RQSPQEHFRRPPQEH

RBM12B

716

Q8IXT5
AAAATRTARQHPPAD

HNRNPDL

101

O14979
APDPHSREARQQRFA

NR1H3

241

Q13133
QPENHASAFPRARRQ

FHDC1

626

Q9C0D6
LQDANDNAPRFLRPH

DCHS1

2161

Q96JQ0
GDRDSARRAPQAFEH

JCAD

1161

Q9P266
EASLERNPNHRPRAA

MAP3K8

366

P41279
HVRDVNDSPPRFSEQ

FAT2

1861

Q9NYQ8
RQASPLVHRRDSNPF

KCNN3

156

Q9UGI6
PPHTARAALRQAFQD

MMP19

121

Q99542
RDVNDHAPRFPRAQI

PCDH8

126

O95206
PHEERQARFQNACRD

CBFB

36

Q13951
AQPQRHFRVERSQPV

EPS8L2

606

Q9H6S3
SHPDKNFPARNRAED

PTPRQ

536

Q9UMZ3
RVNDVNDHSPRFPLD

DCHS2

156

Q6V1P9
PSDYADRRSQHEPQF

RIMS2

301

Q9UQ26
GDIFRQPANREARHS

CHRDL1

191

Q9BU40
LDLPDNPRNRHFTNS

CHMP7

396

Q8WUX9
LDNSARFRPHQDANP

CEMIP2

751

Q9UHN6
NRYSSRNFPAERHNP

LARP4

401

Q71RC2
RPRAETHQRSAEAQP

FOXL1

156

Q12952
DLRRNHFPSVPRAAF

CHADL

431

Q6NUI6
AAHQPFPRPRFRQET

ISM1

76

B1AKI9
SRAFHEIRARNPAFQ

METTL17

171

Q9H7H0
FPENPRADSHRNSDV

PRRT3

61

Q5FWE3
SPQREPQRVSHEQFR

PAK4

291

O96013
ERNDAAPTNHRRPGE

FAM181A

11

Q8N9Y4
RREQASANHPAAAPS

JARID2

261

Q92833
RVRDINDHAPEFPAR

PCDHB6

121

Q9Y5E3
RRHSRDQAQALAADP

RSPH6A

26

Q9H0K4
PDQSHPALRRASRFA

RNF135

241

Q8IUD6
NLPPLRAAHRRFNFD

SMG5

736

Q9UPR3
DPQSRDARQQRFAHF

NR1H2

256

P55055
PGAEARVRAEFRQHA

SDHAF1

26

A6NFY7
RQQQEATPPAHRAAA

SSTR5

341

P35346
HPRADFNRRRTNEPQ

STC1

206

P52823
RRQHAFVPEPFDGAN

ASPRV1

96

Q53RT3
PRQAQRVAHADVFAP

CHPF

551

Q8IZ52
DDRPQVLQPHRLRSF

ZBTB21

396

Q9ULJ3
RRPADTQSRSHFPRD

ZBP1

366

Q9H171
SRSRSPNRFDAHDPR

SPEN

186

Q96T58
PRRNARRLPQDHADS

RNF4

76

P78317
QRAPRDAPVALAQRH

PYCARD-AS1

36

I3L0S3
SSFFQRDRPARHPQE

PRR4

116

Q16378
HFSQANREPRPREAE

TPRN

516

Q4KMQ1
HLFRDASQPVERANP

WDR24

326

Q96S15
NFSRGDERRHEAAVP

ZC3H14

101

Q6PJT7
NHRSEEQPSRRYQPA

ZFYVE26

746

Q68DK2
LAAAFPARPDEQRHR

TNS2

141

Q63HR2